Sponsor or institution
Clinical trials and research at Shenzhen Ionova Life Sciences Co., Ltd.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Shenzhen Ionova Life Sciences Co., Ltd. that are recruiting, at sites in 2 countries (most in China (3), United States (2)). By phase: Phase 1/2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| INV-6452 in adults with HR+/HER2- advanced/metastatic breast cancer or other solid tumors | Phase 1/2 | Shanghai, Shanghai Municipality | Recruiting | May 29, 2026 |
| INV-8989 in KRAS G12D-mutant advanced solid tumors | Phase 1/2 | Guangzhou, Guangdong | Recruiting | May 28, 2026 |
| Evaluating INV-9956 for advanced prostate cancer | Phase 1/2 | Scottsdale, Arizona and 21 other locations | Recruiting | Sep 23, 2024 |
| INV-1120 alone and with pembrolizumab for adults with advanced solid tumors | Phase 1 | Lafayette, Indiana and 2 other locations | Recruiting | Jun 23, 2020 |
All recruiting trials (4)
-
INV-6452 in adults with HR+/HER2- advanced/metastatic breast cancer or other solid tumors
This study tests INV-6452 to see if it is safe and tolerable and to get a first look at its activity in adults with HR+/HER2- advanced breast cancer or other advanced solid tumors.
-
INV-8989 in KRAS G12D-mutant advanced solid tumors
This study tests INV-8989 to see if it can be safely given and potentially help patients with KRAS G12D-mutant advanced solid tumors.
-
Evaluating INV-9956 for advanced prostate cancer
This study is testing a new drug called INV-9956 to see if it can safely help adults with advanced prostate cancer that doesn't respond to hormone therapy.
-
INV-1120 alone and with pembrolizumab for adults with advanced solid tumors
This Phase 1 study will test whether the experimental drug INV-1120, given alone or with pembrolizumab, is safe and tolerable in adults with advanced solid tumors who have progressed after standard therapies.
Quick answers
How many clinical trials run by Shenzhen Ionova Life Sciences Co., Ltd. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.